Serum Institute Covishield booster shot to be available at Rs 600 per shot for individuals above 18 years Ruchika Sharma9 April 2022 12:12 PM IST"End-users will pay Rs 600 for the booster dose and the hospitals will get at a discounted price," Poonawalla said in a statement.
Serum Institute seeks DCGI emergency use nod for rBCG tuberculosis vaccine Ruchika Sharma28 March 2022 12:00 PM ISTNew Delhi: The Serum Institute has applied to the Drugs Controller General of India seeking emergency use authorisation for its recombinant BCG (rBCG)...
SII Covovax gets DCGI emergency use nod for 12 to 18 year olds Ruchika Sharma24 March 2022 12:09 PM ISTCovovax is the fourth vaccine to receive EUA from DCGI for use among adolescents 12 and older.
Heath Bulletin 8/February/2022 Roshni Dhar8 Feb 2022 5:38 PM ISTHere are Top health stories of the daySchools, colleges reopen in Delhi, 4 other states as covid cases drop Kerala based Hepatologist lands in soup...
SII proposal to manufacture Omicron vaccine for analysis gets DCGI nod Ruchika Sharma8 Feb 2022 12:06 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) has approved Serum Institute of India's proposal to manufacture a vaccine against omicron...
Covid-19: Covaxin, Covishield prices likely to be capped at Rs 275 per dose Ruchika Sharma27 Jan 2022 12:15 PM ISTNew Delhi: The price of Covishield and Covaxin, the Covid vaccines which are expected to soon get regular market approval from India's drug regulator,...
Novavax files data with USFDA to back COVID vaccine Ruchika Sharma1 Jan 2022 10:00 AM ISTGaithersburg: Novavax, Inc. has announced that the company has completed submission of the final data package, including the complete chemistry,...
Covovax nod to strengthen immunization efforts in India: SII Roshni Dhar31 Dec 2021 10:30 AM ISTVaccine major serum institute of India (SII) on Tuesday said the approval for the covid-19 vaccine 'covovax' would strength immunization across India...
Immunization efforts in India, lower, middle income countries to strengthen with Covovax approval, says SII Ruchika Sharma29 Dec 2021 2:14 PM ISTCovovax is produced by Pune-based SII under licence from Novavax.
Anti-COVID pill Molnupiravir, Covovax, Corbevax get CDSCO panel emergency use nod Ruchika Sharma28 Dec 2021 11:19 AM ISTAll the recommendations have been sent to the Drug Controller General of India (DCGI) for final approval.
DCGI seeks Serum Institute to submit more data for Covovax emergency authorization Ruchika Sharma25 Dec 2021 2:18 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) has raised queries and sought more data from Serum Institute of India over its application...
Serum Institute waives indemnity over AstraZeneca COVID vaccine for refugees Ruchika Sharma24 Dec 2021 9:00 AM ISTNew Delhi: The Serum Institute of India (SII) has waived its protection from legal liabilities for any AstraZeneca-Oxford COVID-19 shots it supplies...
